DOD Biotech PCL (BKK:DOD) Debt-to-Asset : 0.04 (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is DOD Biotech PCL Debt-to-Asset?

DOD Biotech PCL's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ฿45.8 Mil. DOD Biotech PCL's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ฿0.3 Mil. DOD Biotech PCL's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2024 was ฿1,286.3 Mil. DOD Biotech PCL's debt to asset for the quarter that ended in Dec. 2024 was 0.04.

DOD Biotech PCL Debt-to-Asset Historical Data

The historical data trend for DOD Biotech PCL's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DOD Biotech PCL Debt-to-Asset Chart

DOD Biotech PCL Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Debt-to-Asset

Get a 7-Day Free Trial

0.12

0.11

0.18

0.12

0.04

DOD Biotech PCL Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Debt-to-Asset	Get a 7-Day Free Trial															0.12	0.11	0.12	0.05	0.04

Competitive Comparison of DOD Biotech PCL's Debt-to-Asset

For the Packaged Foods subindustry, DOD Biotech PCL's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DOD Biotech PCL's Debt-to-Asset Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, DOD Biotech PCL's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where DOD Biotech PCL's Debt-to-Asset falls into.

Save Embed

;

Save Embed

;

DOD Biotech PCL Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

DOD Biotech PCL's Debt-to-Asset for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(45.77	+	0.286)	/	1286.313
	=	0.04

DOD Biotech PCL's Debt-to-Asset for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(45.77	+	0.286)	/	1286.313
	=	0.04

DOD Biotech PCL (BKK:DOD) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

DOD Biotech PCL Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of DOD Biotech PCL's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

DOD Biotech PCL Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » DOD Biotech PCL (BKK:DOD) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

DOD-R:Thailand

Address

No. 111, Moo 2, Tumbol Taa jeen, Amphor Muengsamutsakhon, Samut Sakhon, THA, 74000

Website

https://www.dodbiotech.com

DOD Biotech PCL is principally engaged in the manufacture and distribution of food supplements and health drinks of all kinds. The company is organized into business units based on its products and services and has reportable segments as; Supplementary business, Manufacturing cosmetic business, Manufacturing extraction business, and others. A majority of its revenue is generated from the Supplementary business which manufactures and sells dietary supplements in the form of capsules, tablets, soft gels, gummies, probiotics, shot drinks, and others. Geographically, the company operates only in Thailand.

DOD Biotech PCL Headlines

No Headlines